Search results
Up 40%: Is This Red-Hot Growth Stock Still a Buy?
Motley Fool via Yahoo Finance· 2 months agoLast Friday, Agenus (NASDAQ: AGEN), an immuno-oncology player, saw its shares soar by a staggering 40.8%. This remarkable rally occurred seemingly...
Exelixis' (EXEL) Cabozantinib Combo Study Fails to Meet Goal
Zacks via Yahoo Finance· 1 year agoShares of Exelixis, Inc. EXEL were down 0.17% on Mar 3 after the company announced the failure of...
Exelixis (EXEL) Surges 25.4% so Far in 2023: Here's Why
Zacks via Yahoo Finance· 1 year agoExelixis, Inc. EXEL shares surged 25.4% in the year so far against the industry’s decline of 5.2%....
BioNTech SE (NASDAQ:BNTX) Q4 2022 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 1 year agoBioNTech SE (NASDAQ:BNTX) Q4 2022 Earnings Call Transcript March 27, 2023 Michael Horowicz: Good...
Cue Biopharma, Inc. (NASDAQ:CUE) Q3 2023 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 7 months agoCue Biopharma, Inc. (NASDAQ:CUE) Q3 2023 Earnings Call Transcript November 11, 2023 Operator: Good...
NextCure (NXTC) Down on Shelving Plans to Develop Candidate
Zacks via Yahoo Finance· 6 months agoShares of NextCure, Inc. NXTC slumped 19.3% after it announced that it shunned plans further to...
Exelixis (EXEL) Announces Preliminary Q4 and 2022 Results
Zacks via Yahoo Finance· 1 year agoExelixis EXEL announced preliminary financial results for the fourth quarter and full year 2022 and...
Cullinan Oncology Inc (CGEM) Reports Fourth Quarter and Full Year 2023 Financial Results
GuruFocus.com via Yahoo Finance· 3 months agoCash Position: $468.3 million in cash and investments as of December 31, 2023, expected to fund operations into the second half of 2026. R&D Expenses: Increased to $34.8 million in Q4 2023 from ...
Q2 2023 Cue Biopharma Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 10 months agoParticipants Anish Suri; President & Chief Scientific Officer; Cue Biopharma, Inc. Daniel R. Passeri; CEO & Director; Cue Biopharma, Inc. Kerri-Ann Millar; CFO; Cue Biopharma, Inc. Matteo Levisetti ...
12 Most Undervalued Pharma Stocks To Buy According To Hedge Funds
Insider Monkey via Yahoo Finance· 1 year agoIn this article, we discuss 12 most undervalued pharma stocks to buy according to hedge funds. If...
